SAPTANA

Serial Number 88197349
606

Registration Progress

Application Filed
Nov 16, 2018
Under Examination
Aug 6, 2019
Approved for Publication
Jun 11, 2019
Published for Opposition
Jun 11, 2019
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SAPTANA
Previous Owner: Saptalis Pharmaceuticals, LLC
Classes: 005

Trademark Image

SAPTANA

Basic Information

Serial Number
88197349
Filing Date
November 16, 2018
Published for Opposition
June 11, 2019
Abandonment Date
September 12, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 12, 2022
Classes
005

Rights Holder

Saptalis Pharmaceuticals, LLC

16
Address
45 Davids Drive
Hauppauge, NY 11788

Ownership History

Saptalis Pharmaceuticals, LLC

Original Applicant
16
Hauppauge, NY

Saptalis Pharmaceuticals, LLC

Owner at Publication
16
Hauppauge, NY

Legal Representation

Attorney
Steve Roth

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

38 events
Date Code Type Description Documents
Sep 12, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 12, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 12, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 5, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 12, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 5, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 20, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 20, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 20, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 3, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 1, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 1, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 1, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 22, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 20, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 20, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 20, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 30, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 28, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 28, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 28, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 6, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 11, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 11, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 22, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 6, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 2, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 2, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 29, 2019 ALIE A ASSIGNED TO LIE Loading...
Mar 25, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 22, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 22, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 22, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 20, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 4, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 20, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Full line of prescription and over-the-counter pharmaceutical preparations for humans

Classification

International Classes
005